(2S,3R,4S)-4-Hydroxyisoleucine (Synonyms: (4S)-4-Hydroxy-L-isoleucine, 4-OH-Ile) |
| Katalog-Nr.GC38874 |
(2S,3R,4S)-4-Hydroxyisoleucin ist eine oral wirksame Verbindung, die aus Trigonella foenum-graecum isoliert wurde, mit antidiabetischer und antidiabetischer Nephropathie-AktivitÄt.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 55399-93-4
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
(2S,3R,4S)-4-Hydroxyisoleucine is an orally active compound isolated from Trigonella foenum-graecum, with anti-diabetes and anti-diabetic nephropathy activity[1].
[1]. Shi X, et al. Engineering a short-chain dehydrogenase/reductase for the stereoselective production of (2S,3R,4S)-4-hydroxyisoleucine with three asymmetric centers. Sci Rep. 2017 Oct 20;7(1):13703.
Average Rating: 5 (Based on Reviews and 38 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *